Dr. Cano currently holds a postdoctoral researcher position in the clinical research department of Ace Alzheimer Center Barcelona.

Previously, she was an adjunct professor of Physical Chemistry at the University of Barcelona.

She graduated from Pharmacy at the University of Salamanca in 2013 and received her master’s degree in 2014 from the University of Barcelona.

In 2018, she finished her PhD. studies on nanomedicine and neuropharmacology, and obtained the doctoral degree from the University of Barcelona.

She carried out several international research stays at the University of Trás-os-Montes and Alto Douro in Portugal, the University College of London in the United Kingdom, and the University of Modena and Reggio Emilia in Italy.

She is a member of the Consolidated Research Group of the Generalitat de Catalunya “Nanostructured systems for the controlled release of drugs” (2017SGR-1477), Institute of Nanoscience and Nanotechnology (IN2UB), and Center for Biomedical Research in Neurodegenerative Diseases Network (CIBERNED).

Dr. Cano has participated in several competitive European and national projects and published more than 40 scientific papers. She is in charge of the molecular biology unit of Ace Alzheimer Center Barcelona and her studies are related to the clinical evaluation of early biomarkers of Alzheimer’s disease.